The present invention relates to selective NK-1 receptor antagonists of Formula (I) or a pharmaceutically acceptable salt thereof, for the treatment of disorders associated with an excess of tachykinins.

 
Web www.patentalert.com

< Amino acid and peptide conjugates of amiloride and methods of use thereof

< Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof

> Phosphodiesterase 10 inhibitors

> Method for treating neuropathic pain and associated syndromes
~ 00275